Amino acid polymorphism Gly 972 Arg in IRS-1 is not associated to lower clamp-derived insulin sensitivity in young healthy first degree relatives of patients with type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue 5, 1999, Pages 318-322

  Koch, M ^a   Rett, K ^a   Volk, A ^a   Maerker, E ^a   Haist, K ^a   Deninger, M ^a   Renn, W ^a   Haring H U ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Gly 972 Arg mutation; Insulin receptor substrate 1; Insulin resistance; Insulin secretion; Type 2 diabetes

Indexed keywords

AMINO ACID; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CODON; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; IMPEDANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PATHOGENESIS; PRIORITY JOURNAL; RELATIVE;

EID: 0032878846     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212119     Document Type: Article

References (14)

1. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O: Ammoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342: 828-832, 1993
2. Almind K, Inoue G, Pedersen O, Kahn CR: A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97: 2569-2575, 1996
3. Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther, K: Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346: 397-402, 1995
4. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-223, 1979
5. Eriksson J, Franssila Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Gropp L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321: 337-343, 1989
6. Hager J, Zouali H, Velho G, Froguel P: Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families. Lancet 342: 1430, 1993
7. Hitman GA, Hawrami K, McCarthy MI, Viswanathan M, Snehaltha C, Ramachandran A; Tuomilehto J, Tuomilehto Wolf E, Nissininen A, Pedersen O: Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease. Diabetologia 38: 481-486, 1995
8. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77: 98-105, 1986
9. Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473-486, 1995
10. Shimokawa K, Kadowaki H, Sakura H, Otabe S, Hagura R, Kosaka K, Yazaki Y, Akanuma Y, Kadowaki T: Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 202: 463-469, 1994
11. Sigal RJ, Doria A, Warram JH, Krolewski AS: Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81 (4): 1657-1659, 1998
12. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113: 909-915, 1990
13. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 277: 925-926, 1997
14. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, Burns DK, Roth J, Shuldiner AR: Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12A1a PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241: 270-274, 1998